OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
Nicola Potere, Marco Giuseppe Del Buono, Roberto Caricchio, et al.
EBioMedicine (2022) Vol. 85, pp. 104299-104299
Open Access | Times Cited: 78
Nicola Potere, Marco Giuseppe Del Buono, Roberto Caricchio, et al.
EBioMedicine (2022) Vol. 85, pp. 104299-104299
Open Access | Times Cited: 78
Showing 1-25 of 78 citing articles:
The role of NOD-like receptors in innate immunity
Cássio Luiz Coutinho Almeida-da-Silva, Luiz Eduardo Baggio Savio, Robson Coutinho‐Silva, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 59
Cássio Luiz Coutinho Almeida-da-Silva, Luiz Eduardo Baggio Savio, Robson Coutinho‐Silva, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 59
Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 24
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 24
cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation
Jingwen Liu, Jing Zhou, Yuling Luan, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Jingwen Liu, Jing Zhou, Yuling Luan, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 22
An overview of anti-SARS-CoV-2 and anti-inflammatory potential of baicalein and its metabolite baicalin: Insights into molecular mechanisms
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115629-115629
Closed Access | Times Cited: 34
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115629-115629
Closed Access | Times Cited: 34
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
Nicola Potere, Evan C. Garrad, Yogendra Kanthi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2046-2060
Open Access | Times Cited: 30
Nicola Potere, Evan C. Garrad, Yogendra Kanthi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2046-2060
Open Access | Times Cited: 30
Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism
Nicola Potere, Antonio Abbate, Yogendra Kanthi, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 9, pp. 1245-1261
Open Access | Times Cited: 29
Nicola Potere, Antonio Abbate, Yogendra Kanthi, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 9, pp. 1245-1261
Open Access | Times Cited: 29
Inflammasome: structure, biological functions, and therapeutic targets
Dai Ya-li, Jing Zhou, Chunmeng Shi
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 27
Dai Ya-li, Jing Zhou, Chunmeng Shi
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 27
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivo
Stefanie M. Bader, James P. Cooney, Reet Bhandari, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Stefanie M. Bader, James P. Cooney, Reet Bhandari, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Therapeutic effects of tetrandrine in inflammatory diseases: a comprehensive review
Jiawen Song, Yushi Liu, Yurou Guo, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1743-1757
Closed Access | Times Cited: 8
Jiawen Song, Yushi Liu, Yurou Guo, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1743-1757
Closed Access | Times Cited: 8
NLRP3, the inflammasome and COVID-19 infection
Maureen Yin, Laura Marrone, Christian G. Peace, et al.
QJM (2023) Vol. 116, Iss. 7, pp. 502-507
Open Access | Times Cited: 16
Maureen Yin, Laura Marrone, Christian G. Peace, et al.
QJM (2023) Vol. 116, Iss. 7, pp. 502-507
Open Access | Times Cited: 16
COVID-19 in the Initiation and Progression of Atherosclerosis
Vignesh Chidambaram, Amudha Kumar, Murrium I. Sadaf, et al.
JACC Advances (2024) Vol. 3, Iss. 8, pp. 101107-101107
Open Access | Times Cited: 6
Vignesh Chidambaram, Amudha Kumar, Murrium I. Sadaf, et al.
JACC Advances (2024) Vol. 3, Iss. 8, pp. 101107-101107
Open Access | Times Cited: 6
Caspase-1 activation, IL-1/IL-6 signature and IFNγ-induced chemokines in lungs of COVID-19 patients
Audrey Cambon, Christophe Guervilly, Clémence Delteil, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Audrey Cambon, Christophe Guervilly, Clémence Delteil, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
Hiam Naiditch, Michael R. Betts, H. Benjamin Larman, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Hiam Naiditch, Michael R. Betts, H. Benjamin Larman, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Viral reactivations and fungal infections in nonresolving acute respiratory distress syndrome
Lenn Maessen, Leonoor S. Boers, Jannes Heylen, et al.
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240153-240153
Open Access
Lenn Maessen, Leonoor S. Boers, Jannes Heylen, et al.
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240153-240153
Open Access
Neutrophils and COVID-19
Jasmin Šutković
Progress in molecular biology and translational science (2025)
Closed Access
Jasmin Šutković
Progress in molecular biology and translational science (2025)
Closed Access
Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?
Chuan-Han Deng, Tianqi Li, Wei Zhang, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1451-1451
Open Access | Times Cited: 11
Chuan-Han Deng, Tianqi Li, Wei Zhang, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1451-1451
Open Access | Times Cited: 11
Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention
David R. Sweet, Michael L. Freeman, David A. Zidar
Pathogens and Immunity (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 10
David R. Sweet, Michael L. Freeman, David A. Zidar
Pathogens and Immunity (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Recent progress and prospects for anti-cytokine therapy in preclinical and clinical acute lung injury
Guilherme Pasetto Fadanni, João Β. Calixto
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 13-25
Closed Access | Times Cited: 10
Guilherme Pasetto Fadanni, João Β. Calixto
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 13-25
Closed Access | Times Cited: 10
SARS-CoV-2 S1 subunit produces a protracted priming of the neuroinflammatory, physiological, and behavioral responses to a remote immune challenge: A role for corticosteroids
Matthew G. Frank, Jayson B. Ball, Shelby Hopkins, et al.
Brain Behavior and Immunity (2024) Vol. 121, pp. 87-103
Closed Access | Times Cited: 3
Matthew G. Frank, Jayson B. Ball, Shelby Hopkins, et al.
Brain Behavior and Immunity (2024) Vol. 121, pp. 87-103
Closed Access | Times Cited: 3
A meta analysis on the utility of Anakinra in severe COVID-19 disease
Aliaë Mohamed-Hussein, Reem Sayad, Abdelrahman Abdelshafi, et al.
Cytokine (2023) Vol. 169, pp. 156311-156311
Closed Access | Times Cited: 8
Aliaë Mohamed-Hussein, Reem Sayad, Abdelrahman Abdelshafi, et al.
Cytokine (2023) Vol. 169, pp. 156311-156311
Closed Access | Times Cited: 8
Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people
Johanne Poisson, Carine El-Sissy, Arnaud Serret-Larmande, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Johanne Poisson, Carine El-Sissy, Arnaud Serret-Larmande, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Association of the C3953T (rs1143634) variant of the interleukin 1 beta gene with the features of a complicated course of COVID-19-associated pneumonia
V. І. Pokhylko, Yuliia Cherniavska, Liliia Fishchuk, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
V. І. Pokhylko, Yuliia Cherniavska, Liliia Fishchuk, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Characterization of a small molecule inhibitor of the NLRP3 inflammasome and its potential use for acute lung injury
Yiming Xu, Savannah Biby, Chunqing Guo, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107562-107562
Closed Access | Times Cited: 2
Yiming Xu, Savannah Biby, Chunqing Guo, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107562-107562
Closed Access | Times Cited: 2
Autism spectrum disorder and a possible role of anti-inflammatory treatments: experience in the pediatric allergy/immunology clinic
Harumi Jyonouchi
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Harumi Jyonouchi
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
